USA TODAY/
A COVID vaccine being developed by New Jersey-based Johnson & Johnson could dramatically speed up the fight against the pandemic because, unlike the two vaccines already in use, this one would require only one dose and would not need to be stored at super-cold temperatures.
Results from clinical trials of the new vaccine – developed and produced by Johnson & Johnson’s Janssen division – are expected by the end of this month. The vaccine could become the third authorized by the federal Food and Drug Administration.
“If it comes through, that’s a game-changer,” Gov. Phil Murphy said.
Johnson & Johnson had promised 100 million doses of its vaccine to the U.S. government by the end of the year. Leaders of Operation Warp Speed, the federal program to develop and manufacture a COVID vaccine, said this month that unspecified production issues likely would slow the arrival of the initial doses.
0Justice Ayokunle Faji has adjourned further proceedings in the suit filed by Barbican Capital Limited…
Segun Atanda/ The Los Angeles City Council has approved a sweeping "sanctuary city" ordinance designed…
Segun Atanda/ New York prosecutors have opposed dismissing President-elect Donald Trump’s conviction for falsifying business…
Femi Ashekun/ In a bold and controversial move, Musiliu ‘MC Oluomo’ Akinsanya, has defied a…
Matilda Omonaiye/ President Bola Ahmed Tinubu has dissolved the Governing Council of Nnamdi Azikiwe University,…
The Nigerian Consumer Credit Corporation (CREDICORP) has officially launched Project S.C.A.L.E. (Securing Consumer Access for…